LMR Partners »

Black Diamond Therapeutics shares owned by LMR Partners

Quarter-by-quarter ownership of Black Diamond Therapeutics (BDTX) shares owned by LMR Partners from 13F filings

Historical chart of LMR Partners investment in Black Diamond Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Black Diamond Therapeutics held by LMR Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Black Diamond Therapeutics by LMR Partners

Quarter filed Position value Share count Share price at filing
2024-09-30 $898k 206k 4.35
2024-03-31 $53k 10k 5.07

More positions owned by LMR Partners

Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Ishares Tr Russell 2000 Etf (IWM)
NVIDIA Corporation Put Option (NVDA)
Vaneck Etf Trust Semiconductr Etf Put Option (SMH)
Microstrategy Cl A New (MSTR)
Advanced Micro Devices Put Option (AMD)
Capri Holdings SHS Call Option (CPRI)
Tesla Motors (TSLA)
Apple Put Option (AAPL)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Endeavor Group Hldgs Cl A Com (EDR)
Microsoft Corporation (MSFT)
Moderna (MRNA)
Albertsons Cos Common Stock Call Option (ACI)
Dish Network Corporation Note 3.375% 8/1 (Principal)

View all positions for LMR Partners

Top funds holding Black Diamond Therapeutics

T. Rowe Price Investment Management
Bellevue Group
Vestal Point Capital
NEA Management Company
BlackRock
BlackRock
Vanguard Group
Ikarian Capital
Tang Capital Management
Siren
Geode Capital Management
ExodusPoint Capital Management
Citadel Advisors
Kennedy Capital Management
Point72 Asset Management

View all funds holding Black Diamond Therapeutics